Switzerland Opens Cannabis Research Center
Pure Cannabis Research AG and Pure Holding AG announced the establishment of the Cannabis Research Center (CRC) in early September 2018. The CRC, located in Switzerland, will reportedly facilitate cutting-edge research on cannabis. In collaboration with ETH Zurich, NRGene, Israel, and other global partners, Pure Cannabis Research AG plans to significantly improve the methods of plant breeding.
According to a press release from the company, more than 10,000 cannabis plants will be measured and analyzed in these very complex studies. The knowledge and data gained from those studies will be used in combination with proprietary genomic data to allow for the assembly of suites of complex traits in a multitude of different combinations. The company states that aroma profiles, pest and fungus resistance, flower colors, growth rate, and other plant characteristics will no longer be left to chance.
"It's fascinating how this market has developed. Proper resource allocation leads to a win–win situation for the industry and mankind,” said Stevens Senn, CEO of Pure Holding AG, in the press release. “The knowledge gained from the science is beneficial for society as well as for the market. The cannabis plant has an incredible potential. And, thanks to the research center, we will be able to scrutinize and realize this potential” he said.
"We will be able to greatly contribute to scientific findings,” added Yannik Schlup, CBO of Pure Cannabis Research AG referring to the mission of Pure Cannabis Research AG. “The cannabis plant is profoundly valuable as a source of phytopharmaceuticals with the capacity to improve the lives of millions of people."
For more information, please visit the company website at www.pureeurope.eu.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
